{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T18:46:47Z","timestamp":1754160407258,"version":"3.41.2"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,26]]},"DOI":"10.7759\/cureus.88800","type":"journal-article","created":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T11:51:06Z","timestamp":1753530666000},"source":"Crossref","is-referenced-by-count":0,"title":["Necrotizing Fasciitis Treatment With Chlorine Dioxide: A Case Report in an Immunocompromised Patient"],"prefix":"10.7759","author":[{"given":"Patricia","family":"Callisperis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Franco-Paredes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitchell B","family":"Liester","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2147\/RMHP.S77691","article-title":"Necrotizing fasciitis: risk factors of mortality","volume":"8","author":"Khamnuan P","year":"2015","unstructured":"Khamnuan P, Chongruksut W, Jearwattanakanok K, Patumanond J, Yodluangfun S, Tantraworasin A. Necrotizing fasciitis: risk factors of mortality. Risk Manag Healthc Policy. 2015, 8:1-7. 10.2147\/RMHP.S77691","journal-title":"Risk Manag Healthc Policy"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2017.00036","article-title":"Fournier\u2019s gangrene: lessons learned from multimodal and multidisciplinary management of perineal necrotizing fasciitis","volume":"4","author":"Ioannidis O","year":"2017","unstructured":"Ioannidis O, Kitsikosta L, Tatsis D, et al.. Fournier\u2019s gangrene: lessons learned from multimodal and multidisciplinary management of perineal necrotizing fasciitis. Front Surg. 2017, 4:36. 10.3389\/fsurg.2017.00036","journal-title":"Front Surg"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2014.00036","article-title":"Current concepts in the management of necrotizing fasciitis","volume":"1","author":"Misiakos EP","year":"2014","unstructured":"Misiakos EP, Bagias G, Patapis P, Sotiropoulos D, Kanavidis P, Machairas A. Current concepts in the management of necrotizing fasciitis. Front Surg. 2014, 1:36. 10.3389\/fsurg.2014.00036","journal-title":"Front Surg"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.9371","article-title":"Early diagnosis of necrotizing fasciitis","volume":"101","author":"Goh T","year":"2014","unstructured":"Goh T, Goh LG, Ang CH, Wong CH. Early diagnosis of necrotizing fasciitis. Br J Surg. 2014, 101:e119-25. 10.1002\/bjs.9371","journal-title":"Br J Surg"},{"key":"ref5","article-title":"Overall View of ClO2","author":"Alliger H","year":"2025","unstructured":"Alliger H. Overall View of ClO2. Frontier Pharmaceutical, Inc., Melville; 2025."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/jambio\/lxad133","article-title":"Antimicrobial efficiency of chlorine dioxide and its potential use as anti-SARS-CoV-2 agent: mechanisms of action and interactions with gut microbiota","volume":"134","author":"Peredo-Lovillo A","year":"2023","unstructured":"Peredo-Lovillo A, Romero-Luna HE, Ju\u00e1rez-Trujillo N, Jim\u00e9nez-Fern\u00e1ndez M. Antimicrobial efficiency of chlorine dioxide and its potential use as anti-SARS-CoV-2 agent: mechanisms of action and interactions with gut microbiota. J Appl Microbiol. 2023, 134:10.1093\/jambio\/lxad133","journal-title":"J Appl Microbiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.5897\/IJMMS2023.1503","article-title":"Chlorine dioxide and chlorite as treatments for diabetic foot ulcers","volume":"16","author":"Calliperis P","year":"2024","unstructured":"Calliperis P, Andrade Y, Aquino RP, Vargas M, Kota SR, Liester M. Chlorine dioxide and chlorite as treatments for diabetic foot ulcers. Int J Med Med Sci. 2024, 16:1-14. 10.5897\/IJMMS2023.1503","journal-title":"Int J Med Med Sci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/468764","article-title":"A comparison of wound healing rate following treatment with aftamed and chlorine dioxide gels in streptozotocin-induced diabetic rats","volume":"2012","author":"Al-Bayaty F","year":"2012","unstructured":"Al-Bayaty F, Abdulla MA. A comparison of wound healing rate following treatment with aftamed and chlorine dioxide gels in streptozotocin-induced diabetic rats. Evid Based Complement Alternat Med. 2012, 2012:468764. 10.1155\/2012\/468764","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcte.2016.05.001","article-title":"The chlorite-based drug WF10 constantly reduces hemoglobin A1c values and improves glucose control in diabetes patients with severe foot syndrome","volume":"4","author":"Maraprygsavan P","year":"2016","unstructured":"Maraprygsavan P, Mongkolsuk J, Arnhold J, Kuehne FW. The chlorite-based drug WF10 constantly reduces hemoglobin A1c values and improves glucose control in diabetes patients with severe foot syndrome. J Clin Transl Endocrinol. 2016, 4:53-8. 10.1016\/j.jcte.2016.05.001","journal-title":"J Clin Transl Endocrinol"},{"key":"ref10","unstructured":"Toxicological profile for chlorine dioxide and chlorite. (2025). Accessed. June 14, 2025: https:\/\/www.atsdr.cdc.gov\/toxprofiles\/tp160.pdf."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3109\/00365528109182002","article-title":"Reticuloendothelial function in patients with alcoholic liver cirrhosis","volume":"16","author":"Lahnborg G","year":"1981","unstructured":"Lahnborg G, Friman L, Berghem L. Reticuloendothelial function in patients with alcoholic liver cirrhosis. Scand J Gastroenterol. 1981, 16:481-9. 10.3109\/00365528109182002","journal-title":"Scand J Gastroenterol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00293","article-title":"Causes and consequences of innate immune dysfunction in cirrhosis","volume":"10","author":"Irvine KM","year":"2019","unstructured":"Irvine KM, Ratnasekera I, Powell EE, Hume DA. Causes and consequences of innate immune dysfunction in cirrhosis. Front Immunol. 2019, 10:293. 10.3389\/fimmu.2019.00293","journal-title":"Front Immunol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2337\/dc18-0287","article-title":"Glycemic control and risk of infections among people with type 1 or type 2 diabetes in a large primary care cohort study","volume":"41","author":"Critchley JA","year":"2018","unstructured":"Critchley JA, Carey IM, Harris T, DeWilde S, Hosking FJ, Cook DG. Glycemic control and risk of infections among people with type 1 or type 2 diabetes in a large primary care cohort study. Diabetes Care. 2018, 41:2127-35. 10.2337\/dc18-0287","journal-title":"Diabetes Care"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1700223","article-title":"Macrophage-mediated inflammation in normal and diabetic wound healing","volume":"199","author":"Boniakowski AE","year":"2017","unstructured":"Boniakowski AE, Kimball AS, Jacobs BN, Kunkel SL, Gallagher KA. Macrophage-mediated inflammation in normal and diabetic wound healing. J Immunol. 2017, 199:17-24. 10.4049\/jimmunol.1700223","journal-title":"J Immunol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/0043-1354(80)90121-9","article-title":"Mode of bacterial inactivation by chlorine dioxide","volume":"14","author":"Roller SD","year":"1980","unstructured":"Roller SD, Olivieri VP, Kawata K. Mode of bacterial inactivation by chlorine dioxide. Water Res. 1980, 14:635-41. 10.1016\/0043-1354(80)90121-9","journal-title":"Water Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1053\/j.jfas.2011.05.006","article-title":"Effect of WF10 (immunokine) on diabetic foot ulcer therapy: a double-blind, randomized, placebo-controlled trial","volume":"50","author":"Yingsakmongkol N","year":"2011","unstructured":"Yingsakmongkol N, Maraprygsavan P, Sukosit P. Effect of WF10 (immunokine) on diabetic foot ulcer therapy: a double-blind, randomized, placebo-controlled trial. J Foot Ankle Surg. 2011, 50:635-40. 10.1053\/j.jfas.2011.05.006","journal-title":"J Foot Ankle Surg"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.5897\/IJMMS2024.1515","article-title":"Chlorine dioxide treatment for diabetic foot ulcers: three case studies","volume":"16","author":"Callisperis P","year":"2024","unstructured":"Callisperis P, Aquino RP, Kota SR, Vargas M, Rodriguez N, Liester M. Chlorine dioxide treatment for diabetic foot ulcers: three case studies. Int J Med Med Sci. 2024, 16:44-9. 10.5897\/IJMMS2024.1515","journal-title":"Int J Med Med Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/384377-necrotizing-fasciitis-treatment-with-chlorine-dioxide-a-case-report-in-an-immunocompromised-patient","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T11:51:07Z","timestamp":1753530667000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/384377-necrotizing-fasciitis-treatment-with-chlorine-dioxide-a-case-report-in-an-immunocompromised-patient"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,26]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.88800","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,7,26]]}}}